Clinical trial
A Randomized, Double-Blind, Placebo Controlled Dose-Ranging Study of Auxora in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome
NCT04681066 is registered in ClinicalTrials.gov with CalciMedica, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo Controlled Dose-Ranging Study of Auxora in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome
- Lead sponsor
- CalciMedica, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 24, 2021
- Completion date
- May 15, 2024
- Enrollment
- 216 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis, systemic inflammatory response syndrome